Research Project
Project Title: |
A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Hereditary glomerulopathies |
Project Summary: |
Evaluate the efficacy and safety of iptacopan compared to placebo (and standard of care) in patients with native C3G. |
Lead principal investigator(s): |
Marina Vivarelli, Rome |
Co-investigator(s): |
Luca Antonucci, Rome Antonio Gargiulo, Rome Chiara Bettini, Rome |
Project Period: |
11/2021 - 12/2060 |
EudraCT Nr.: |
2020-004589-21 |
« Back to research page